Wellgistics sponsored Dream Bowl 2026 and participated in the Datavault AI shareholder distribution plan for the Dream Bowl 2026 meme…
LIXTE has acquired Liora Technologies Europe Ltd., securing its proprietary LiGHT system for advanced proton therapy treatment Liora works at…
Ottawa's latest defense industrial roadmap treats quantum computing as a strategic priority requiring government protection and accelerated development. Quantum sits…
With a focus on energy orchestration software rather than grid hardware or power generation, GridAI addresses the immediate need to…
Brain tumors may damage surrounding tissue in a more insidious way than previously understood. New research from the University of Notre Dame shows that chronic…
In oncology, the biggest constraints are not always science. They are often the logistics, the cost of specialized infrastructure, and…
An already approved cancer drug called Carfilzomib may help restore the effectiveness of CAR-T cell therapy in advanced multiple myeloma cases. Technical…
LIXTE recently announced advances in its approach to cancer therapy through its proprietary compound LB-100 Alongside clinical development news, LIXTE is…
Mass General Brigham researchers have developed a new AI model that can estimate brain age, assess a patient’s risk of developing dementia, and help predict survival…
Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow that the AI boom could…